Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function

The Journal of Clinical Investigation
S RiemersmaJohn Newsom-Davis

Abstract

Arthrogryposis multiplex congenita (AMC), characterized by multiple joint contractures developing in utero, results from lack of fetal movement. Some cases are genetically determined, but AMC occasionally complicates pregnancy in patients with myasthenia gravis (MG) suggesting involvement of circulating maternal antibodies. We previously demonstrated antibodies that inhibited the function of fetal acetylcholine receptor (AChR) in one healthy woman with an obstetric history of recurrent AMC. Here we study sera from this woman, from one other with a similar history, and from three (one asymptomatic) whose babies had neonatal MG and AMC. All five maternal sera had high titers of antibodies that inhibited alpha-Bungarotoxin (alpha-BuTx) binding to fetal AChR, and their sera markedly inhibited fetal AChR function with little effect on adult AChR function. Moreover, in a further survey, 3 of 20 sera from anti-AChR negative AMC mothers inhibited fetal AChR function significantly at 1:100 dilution. These results demonstrate the role of antibodies to fetal AChR and perhaps other muscle antigens in some cases of AMC. More generally, they suggest that placental transfer of antibodies directed at fetal antigens should be considered as a ca...Continue Reading

References

Jan 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C B Weinberg, Z W Hall
Nov 1, 1990·Neurology·H J KaminskiR L Ruff
Jan 1, 1987·Annals of the New York Academy of Sciences·Z W HallS M Schuetze
May 1, 1986·Journal of Neuroimmunology·P J WhitingJ Newsom-Davis
Aug 1, 1987·American Journal of Diseases of Children·N Y Olson, C B Lindsley
Dec 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·A Vincent, J Newsom-Davis
Apr 1, 1970·Archives of Disease in Childhood·R H Jago
Feb 1, 1982·American Journal of Medical Genetics·J G HallG Greene
Jan 1, 1982·Journal of Immunological Methods·B LangJ Newsom-Davis
Oct 1, 1994·Pflügers Archiv : European journal of physiology·R Barrett-JolleyJ Newsom-Davis
Aug 1, 1994·The Journal of Clinical Investigation·B Vernet-der GarabedianJ F Bach
Jun 23, 1994·The New England Journal of Medicine·D B Drachman
Jul 1, 1993·Neuromuscular Disorders : NMD·J Dinger, B Prager

❮ Previous
Next ❯

Citations

Sep 10, 2008·Hand : Official Journal of the American Association for Hand Surgery·David T NetscherEric Lewis
Sep 11, 2002·Journal of the Neurological Sciences·M De Baets, M H W Stassen
Apr 13, 2000·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·C BelascoM Uzan
Aug 26, 2006·Nature Clinical Practice. Nephrology·Pierre RoncoVincent Guigonis
Aug 26, 2006·Nature Clinical Practice. Neurology·Camilla Buckley, Angela Vincent
May 9, 2009·Nature Reviews. Immunology·Betty DiamondBruce T Volpe
Nov 18, 2000·European Journal of Biochemistry·A VincentB Lang
Apr 30, 2005·Journal of Pediatric Gastroenterology and Nutrition·Peter F Whitington, Padmini Malladi
Apr 9, 2013·Clinical Obstetrics and Gynecology·Michael Varner
Jul 21, 1998·Annals of the New York Academy of Sciences·L JacobsonA Vincent
Apr 15, 1999·Annual Review of Neuroscience·K D Whitney, J O McNamara
Jul 13, 2013·Journal of Neurology, Neurosurgery, and Psychiatry·Paul Maddison
Feb 18, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Joel Oger, Hans Frykman
Dec 27, 2011·Autoimmunity Reviews·Graziela CarvalheirasCarlos Vasconcelos
Oct 22, 2008·Progress in Neurobiology·Andrew HubballCharles H Knowles
Nov 25, 2003·International Journal of Experimental Pathology·Katherine J LambAndrew A Pitsillides
Nov 1, 2003·Annals of the New York Academy of Sciences·H ShionoN Willcox
Nov 1, 2003·Annals of the New York Academy of Sciences·Angela VincentWerner Hoch
Dec 21, 2012·Annals of the New York Academy of Sciences·Angela VincentDavid Beeson
Oct 21, 2015·Journal of Children's Orthopaedics·Jana Midelfart Hoff, Anna Midelfart
Nov 9, 2004·Lancet·Peter F Whitington, Judith U Hibbard
Aug 27, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Richard M RansohoffAmit Bar-Or
Aug 22, 2006·Neuromuscular Disorders : NMD·Paola DaltonAngela Vincent
Nov 9, 2005·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·V GuigonisP Ronco
Oct 12, 2004·Neurologic Clinics·Emma Ciafaloni, Janice M Massey
Aug 2, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Simone FerreroNicola Ragni
Aug 5, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Joel Oger, Hans Frykman
Oct 4, 2006·Neuron·Angela VincentKleopas A Kleopa
Aug 2, 2002·Journal of Child Neurology·Nathaniel KhoStephen Coons
Mar 15, 2000·Muscle & Nerve·J M Lindstrom
Nov 2, 2017·Scientific Reports·Abhishek SaxenaPilar Martinez-Martinez
Jun 10, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·Russell C DaleMatthew C Kiernan
Jul 27, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J M HoffN E Gilhus
Nov 19, 2002·Journal of Neurobiology·Jon Lindstrom

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.